We are live on ! Find out more
EP

Elkfork Partners Portfolio holdings

AUM $4.11B
1-Year Est. Return 5.26%
This Fund
S&P 500
This Quarter Est. Return
+4.66%
1 Year Est. Return
+5.26%
3 Year Est. Return
+52.4%
5 Year Est. Return
10 Year Est. Return
AUM
$4.09B
AUM Growth
+$106M
Cap. Flow
-$30.8M
Cap. Flow %
-0.75%
Top 10 Hldgs %
25.55%
Holding
1,074
New
41
Increased
384
Reduced
253
Closed
27

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.8M
2
WAB icon
Wabtec
WAB
+$16.3M
3
DAL icon
Delta Air Lines
DAL
+$15.1M
4
FTV icon
Fortive
FTV
+$13.7M
5
LYB icon
LyondellBasell Industries
LYB
+$9.21M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$18.7M
2
CELG
Celgene Corp
CELG
+$18M
3
INTC icon
Intel
INTC
+$12.5M
4
CTSH icon
Cognizant
CTSH
+$12.4M
5
FTNT icon
Fortinet
FTNT
+$10.3M

Sector Composition

Rank Sector Weight
1 Technology 19.96%
2 Financials 16.17%
3 Consumer Discretionary 12.29%
4 Healthcare 10.9%
5 Industrials 10.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOMO icon
1026
Domo
DOMO
$174M
$24K ﹤0.01%
880
VRNT
1027
DELISTED
Verint Systems
VRNT
$24K ﹤0.01%
879
ALTR
1028
DELISTED
Altair Engineering Inc
ALTR
$23K ﹤0.01%
560
HRTX icon
1029
Heron Therapeutics
HRTX
$93.9M
$22K ﹤0.01%
+1,204
New +$24.1K
MAT icon
1030
Mattel
MAT
$4.38B
$22K ﹤0.01%
1,960
-35,868
-95% -$421K
SSTI icon
1031
SoundThinking
SSTI
$100M
$21K ﹤0.01%
476
-2,380
-83% -$111K
DNLI icon
1032
Denali Therapeutics
DNLI
$3.65B
$19K ﹤0.01%
918
DOCU
1033
DocuSign
DOCU
$10.5B
$18K ﹤0.01%
352
-1,188
-77% -$63.4K
ICL icon
1034
ICL Group
ICL
$6.53B
$17K ﹤0.01%
3,322
+572
+21% +$3.03K
OBSV
1035
DELISTED
ObsEva SA Ordinary Shares
OBSV
$16K ﹤0.01%
1,386
BOX icon
1036
Box
BOX
$4.37B
$15K ﹤0.01%
836
NTNX icon
1037
Nutanix
NTNX
$16B
$15K ﹤0.01%
588
-1,260
-68% -$43.9K
AGIO icon
1038
Agios Pharmaceuticals
AGIO
$1.79B
$14K ﹤0.01%
286
-4,026
-93% -$215K
SGMO
1039
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$14K ﹤0.01%
+1,320
New +$14K
BBIO icon
1040
BridgeBio Pharma
BBIO
$15.7B
$13K ﹤0.01%
+484
New +$13.2K
ECOM
1041
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$11K ﹤0.01%
1,298
VCIT icon
1042
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$10K ﹤0.01%
112
TRQ
1043
DELISTED
Turquoise Hill Resources Ltd
TRQ
$10K ﹤0.01%
854
+55
+7% +$761
AKRO
1044
DELISTED
Akero Therapeutics
AKRO
$9K ﹤0.01%
+484
New +$9.17K
CRNX icon
1045
Crinetics Pharmaceuticals
CRNX
$8.84B
$7K ﹤0.01%
280
ARD
1046
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
$1K ﹤0.01%
+66
New +$963
ALV icon
1047
Autoliv
ALV
$9.02B
-836
Closed -$61K
ASMB icon
1048
Assembly Biosciences
ASMB
$498M
-48
Closed -$11K
BIDU icon
1049
Baidu
BIDU
$37.7B
-880
Closed -$145K
BMRN icon
1050
BioMarin Pharmaceuticals
BMRN
$11.6B
-272
Closed -$24K

Similar funds

Elkfork Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Elkfork Partners held 1,074 positions worth $4.09B, up 2.7% from $3.99B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Elkfork Partners's Q2 2019 filing shows 41 new, 384 increased, 253 reduced and 27 closed positions. Its largest new stake was L3Harris: 31,108 shares worth $5.88M. The largest sale was Linde, an estimated $18.7M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Elkfork Partners's largest Q2 2019 buy was L3Harris: 31,108 shares worth $5.88M.
  • Elkfork Partners added most to Microsoft in Q2 2019, an estimated $17.8M increase.
  • Elkfork Partners's biggest Q2 2019 reduction was Linde, cutting an estimated $18.7M.
  • Elkfork Partners fully exited Burlington in Q2 2019, selling an estimated $1.99M.
  • Elkfork Partners's ten largest holdings make up 26% of its $4.09B portfolio in Q2 2019.
  • Elkfork Partners opened 41 new positions and closed 27 in Q2 2019.
  • Elkfork Partners's portfolio value rose 2.7% quarter-over-quarter to $4.09B.

Based on Elkfork Partners's 13F filing for Q2 2019, filed 13 Aug 2019.